Señales en vivo de IOVA | Maximiza tus Ganancias con Getagraph.com

VENDER 66 min ago

@ $13.88

Emitido: 6 may 2024 @ 15:34

Retorno: 0.04%

Señal anterior: may 6 - 14:57

Señal anterior: Comprar

Retorno: 0.43 %

Live Chart Being Loaded With Signals

Commentary (6 may 2024 @ 16:00):
Our systems believe the stock currently is overvalued by 0.50% compare to its pairs and should correct downwards.

Stats
Volumen de hoy	4.73M
Volumen promedio	9.04M
Capitalización de mercado	3.88B
EPS	$0 ( 2024-02-28 )
Próxima fecha de ganancias	( $-0.450 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-7.34
ATR14	$0.499 (3.60%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-15	Vogt Frederick G	Buy	20 834	Common Stock
2024-04-15	Vogt Frederick G	Sell	8 851	Common Stock
2024-04-15	Vogt Frederick G	Sell	20 834	Restricted Stock Units
2024-04-15	Graf Finckenstein Friedrich	Buy	2 812	Common Stock
2024-04-15	Graf Finckenstein Friedrich	Sell	1 427	Common Stock

INSIDER POWER
94.67
Last 99 transactions
Buy: 13 607 426 \| Sell: 449 378

Correlación (AI algo v.1.1b): Overvalued: -0.50% $13.78 paired level. (El Algoritmo Rastrea Los Cambios De Las Acciones Más Correlacionadas En Tiempo Real Y Proporciona Una Actualización Instantánea)

Volumen Correlación

Largo: 0.05 (neutral)

Corto: -0.14 (neutral)

Signal:(42) Neutral

Iovance Biotherapeutics Correlación

10 Correlaciones Más Positivas
LRMR	0.94
EQ	0.933
CFLT	0.924
POWL	0.916
TARA	0.914
MACK	0.902
PXLW	0.902
CLBT	0.901
MEDP	0.9
KTCC	0.9

10 Correlaciones Más Negativas
SSRM	-0.916
BLKB	-0.911
DCRC	-0.91
SGLB	-0.908
AMRB	-0.9
CAR	-0.886
BIOL	-0.878
WTER	-0.874
CYAN	-0.874
EGAN	-0.868

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Iovance Biotherapeutics Correlación - Moneda/Commodity

0.04
( neutral )

-0.09
( neutral )

0.00
( neutral )

0.37
( neutral )

0.40
( neutral )

-0.32
( neutral )

Iovance Biotherapeutics Finanzas

Annual	2023
Ingresos:	$1.19M
Beneficio Bruto:	$-31.94M (-2 686.12 %)
EPS:	$-1.890

FY	2023
Ingresos:	$1.19M
Beneficio Bruto:	$-31.94M (-2 686.12 %)
EPS:	$-1.890

FY	2022
Ingresos:	$0
Beneficio Bruto:	$-21.14M (0.00 %)
EPS:	$-2.45

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-2.20

Financial Reports:

No articles found.

Iovance Biotherapeutics

Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or persistent cervical cancer; and C-145-03, of its product candidate LN-145, for recurrent and/or metastatic head and neck squamous cell carcinoma. Iovance Biotherapeutics, Inc. has collaborations and licensing agreements with H. Lee Moffitt Cancer Center; M.D. Anderson Cancer Center; Ohio State University; Centre hospitalier de l'Université de Montreal; Cellectis S.A.; and Novartis Pharma AG. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California.

Actualizaciones en tiempo real para Iovance Biotherapeutics [IOVA]

Upcoming Earnings Alert